Young Scientist Award
| SATHISH DYAWANAPELLY |
| Affiliation |
Institute of Chemical Technology (ICT), Mumbai |
| Country |
India |
| Scopus ID |
56293760300 |
| Documents |
39 |
| Citations |
1947 |
| h-index |
24 |
| Subject Area |
Pharmacology and Drug Development |
| Event |
World Life Science Awards |
SATHISH DYAWANAPELLY is a researcher associated with the Institute of Chemical Technology (ICT), Mumbai, whose scholarly work has focused on pharmacology, nanomedicine, drug delivery systems, biomaterials, and pharmaceutical innovation. His research portfolio demonstrates sustained contributions to the advancement of drug development methodologies, polymer therapeutics, pulmonary delivery systems, nanovaccines, and translational pharmaceutical sciences. The combination of publication output, citation performance, and interdisciplinary research engagement provides a basis for consideration within academic recognition programs such as the Young Scientist Award.[1]
Abstract
This article presents an academic overview of SATHISH DYAWANAPELLY and evaluates his suitability for recognition through the Young Scientist Award. The assessment is based on publicly available scholarly indicators including publication productivity, citation performance, research specialization, and documented contributions to pharmaceutical sciences and drug delivery technologies. His work spans nanomedicine, cancer therapeutics, pulmonary formulations, biomimetic nanovaccines, and advanced pharmaceutical engineering, demonstrating interdisciplinary engagement within life science research.[1][2]
Keywords
Nanomedicine, Drug Delivery Systems, Pharmacology, Polymer Therapeutics, Pulmonary Drug Delivery, Pharmaceutical Sciences, Cancer Therapy, Biomaterials, Nanovaccines, Life Sciences.
Introduction
The development of modern therapeutics increasingly relies on innovative drug delivery technologies capable of improving efficacy, safety, and patient outcomes. Researchers working at the intersection of pharmaceutical sciences and nanotechnology contribute substantially to this objective. SATHISH DYAWANAPELLY has developed a research profile centered on advanced delivery systems, polymer-based therapeutics, and translational pharmaceutical technologies, contributing to emerging areas of life science research.[2][3]
Research Profile
Based at the Institute of Chemical Technology (ICT), Mumbai, SATHISH DYAWANAPELLY has established a scholarly record characterized by publications in internationally recognized journals and interdisciplinary collaborations. His Scopus metrics indicate 39 indexed documents, 1,947 citations, and an h-index of 24, reflecting measurable research visibility and influence within pharmacology and drug development.[1]
- Specialization in pharmacology and advanced drug delivery systems.
- Research involvement in nanomedicine and biomaterial-based therapeutics.
Research Contributions
The research contributions of SATHISH DYAWANAPELLY encompass several areas of pharmaceutical innovation. His studies have explored polymer therapeutics, pulmonary drug delivery systems, nanoparticle engineering, biomimetic nanovaccines, and cancer-targeted delivery technologies. These investigations address practical challenges associated with therapeutic effectiveness, bioavailability, and targeted treatment strategies.[2]
- Polymer therapeutics and pharmacokinetic optimization.
- Nanovaccine development and biomimetic delivery technologies.
- Pulmonary drug delivery approaches for chronic diseases.
Publications
Selected publications associated with SATHISH DYAWANAPELLY demonstrate engagement with contemporary pharmaceutical research topics and high-impact translational applications.[2]
- The Holy Grail of Polymer Therapeutics for Cancer Therapy: An Overview on the Pharmacokinetics and Biodistribution.
- Understanding the Nano-Bio Interactions Using Real-Time Surface Plasmon Resonance Tool.
- Multifaceted Therapeutic Applications of Biomimetic Nanovaccines.
Research Impact
Citation metrics, publication quality, and subject relevance collectively indicate that the research activities of SATHISH DYAWANAPELLY have generated measurable scholarly attention. The citation count of 1,947 and h-index of 24 suggest that multiple publications have influenced subsequent investigations within pharmaceutical sciences and drug delivery research. Such indicators are commonly considered when evaluating research significance and scientific visibility.[1]
Award Suitability
The Young Scientist Award recognizes emerging and accomplished researchers who demonstrate innovation, scientific productivity, and meaningful contributions within their disciplines. Based on available scholarly indicators, SATHISH DYAWANAPELLY exhibits characteristics aligned with such recognition, including interdisciplinary research output, citation impact, active publication record, and contributions to pharmaceutical innovation. His work on advanced therapeutic delivery technologies aligns with contemporary priorities in life science and healthcare research.[1][2]
Conclusion
SATHISH DYAWANAPELLY has developed a notable academic profile within pharmacology and drug development through contributions to nanomedicine, drug delivery systems, biomaterials, and therapeutic innovation. The combination of publication productivity, citation performance, and interdisciplinary research engagement supports consideration for academic recognition programs such as the Young Scientist Award under the World Life Science Awards framework.[1]
External Links
References
- Sampathi, S., Tiriya, P. K., Dodoala, S., Junnuthula, V., & Dyawanapelly, S. (2022). Development of biocompatible ciprofloxacin–gold nanoparticle coated sutures for surgical site infections. Pharmaceutics, 14(10), Article 2130.
https://doi.org/10.3390/pharmaceutics14102130
- Parihar, A., Prajapati, B. G., Paliwal, H., Shukla, M., Khunt, D., Bahadure, S. D., Dyawanapelly, S., & Junnuthula, V. (2023). Advanced pulmonary drug delivery formulations for the treatment of cystic fibrosis. Drug Discovery Today, 28(10), Article 103729
https://doi.org/10.1016/j.drudis.2023.103729
- Iyer, G., Dyawanapelly, S., Jain, R., & Dandekar, P. (2022). An overview of oral insulin delivery strategies (OIDS).
https://doi.org/10.1016/j.ijbiomac.2022.03.144